drugset / Trial / NCT02028663
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the optimal dose and administration methods of CJ-12420 in patients with erosive esophagitis by comparing the safety and efficacy of orally administered CJ-12420 to esomeprazole 40mg.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 40 mg | Oral |
| Subject | Tegoprazan | Other / unclassified | — | Oral |